CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BGNE

Gemcitabine Hydrochloride

Phase 3
BeiGene, Ltd. (BGNE)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
BGNEPhase 3

Gemcitabine Hydrochloride Phase 3 Est. Readout

Gemcitabine Hydrochloride
Q2 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Urothelial Carcinoma

View Full Landscape
Drug Information

Target Indication

Urothelial Carcinoma

Clinical Trial

NCT03967977

Last updated: 1/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.